DexCom Inc/ US2521311074 /
2024-05-28 5:50:58 PM | Chg. -0.8200 | Volume | Bid2024-05-28 | Ask2024-05-28 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
126.5500USD | -0.64% | 382,644 Turnover: 29.74 mill. |
126.5400Bid Size: 200 | 126.6000Ask Size: 200 | 50.45 bill.USD | - | 90.61 |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.